IOBT Versus IO-Rec for Hypertropia With IOOA (IIHIOOA)

NCT05415553 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2022-07-29

No results posted yet for this study

Summary

This is a multi-center, randomized double-blind controlled trial to compare the effectiveness of IOBT with IO-Rec for the treatment of hypertropia with IOOA.

Specific Aim 1 (Primary): To study the suboptimal surgical rates between IOBT and IO-Rec for the treatment of hypertropia with IOOA.

Specific Aim 2 (Secondary): To compare the surgical successful rate of IOBT with IO-Rec for the treatment of hypertropia with IOOA.

Conditions

  • Hypertropia
  • Inferior Oblique Overaction

Interventions

PROCEDURE

IOBT

Surgery of inferior oblique muscle belly transposition for treatment of primary position hypertropia with inferior oblique overaction

PROCEDURE

IO-Rec

Surgery of inferior oblique muscle recession for treatment of primary position hypertropia with inferior oblique overaction

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    collaborator OTHER
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • Shanxi Eye Hospital

    collaborator OTHER
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Tianjin Eye Hospital

    collaborator OTHER
  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • Xiamen Eye Center of Xiamen University

    collaborator UNKNOWN
  • Kunming Aier Eye Hospital

    collaborator UNKNOWN
  • Eye & ENT Hospital of Fudan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05415553 on ClinicalTrials.gov